Generate Life Sciences is the combination of California Cryobank and Cord Blood Registry, two leading players in the stem cell storage and reproductive tissue services markets. The combined business will be the #1 player in three highly-complementary end-markets, helping nearly 700,000 families across 30 countries. Both companies operate in resilient, non-cyclical end-markets with no government reimbursement exposure.
Investment Details
- Initial Investment Date: August 2018 to December 2021
- GI Role: Lead Investor
- Status: Realized
